Consistently, Lu et al21 have figured out that reduced HDAC3 inhibited xenograft tumour growth in liver cancer, and Cui et al22 have suggested that miR‐495‐3p contributed to restraining tumour growth in gastric cancer. Here, HDAC3 is linked to gastric cancer.